BridgeMD
New treatment option for Tinea Pedis
Official title Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis
ClinicalTrials.gov ID: NCT07056660
What this study is testing
- What it's testing
- Tinea pedis (athlete's foot) is a common and highly contagious fungal infection of the feet. Moderate-to-severe cases present with extensive skin lesions, severe symptoms, frequent recurrences, and increased risk of complications, often proving refractory to conventional topical therapies.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Age between 18 and 70 years, irrespective of sex.
- Clinical diagnosis of interdigital tinea pedis (non-hyperkeratotic type), with or without extension to other areas, of moderate to severe intensity...
- Positive direct potassium hydroxide (KOH) microscopic examination for dermatophytes.
- Women of childbearing potential will agree to use effective contraception throughout the study period.
- Written informed consent will be obtained prior to enrollment.
You likely can't join if
- Severe bacterial infection or other dermatological conditions that may interfere with study assessments.
- Serious cardiac, hepatic, or renal diseases, diabetes mellitus, or major psychiatric disorders.
- Systemic corticosteroid or immunosuppressant use within the past 3 months.
- Systemic antifungal agents within the past 2 months or topical antifungal agents within the past 2 weeks.
- Pregnancy or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Luoyang, Henan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Luoyang, Henan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.